arrow
返回
F

Francesco Massari

IRCCS Azienda Ospedaliero-Universitaria di Bologna

65H指数
866论文数
1.9W被引数
收录论文 303
发表时间
Reproducible human reward imaging phenotypes exhibit differential sensitivity to dopamine D2 receptor antagonism可复现的人类奖励成像表型对多巴胺D2受体拮抗剂表现出不同的敏感性
err2026-09-03
err0
errOAAI
errNicola Sambuco; Antonella Lupo; Peter C. T. Hawkins; Pierluigi Selvaggi; Linda A. Antonucci; Alessandro Bertolino; Giuseppe Blasi; Piergiuseppe Di Palo; Luigi Grassi; Daniela Grasso; Philipp Homan; Gian Marco Leggio; Francesco Massari; Alessio Maria Monteleone; Martin Osugo; Roberta Passiatore; Alessandra Raio; Antonio Rampino; Tobias Banaschewski; Gareth J. Barker; Arun L. W. Bokde; Rüdiger Brühl; Sylvane Desrivières; Herta Flor; Hugh Garavan; Penny Gowland; Antoine Grigis; Andreas Heinz; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Eric Artiges; Frauke Nees; Dimitri Papadopoulos Orfanos; Luise Poustka; Michael N. Smolka; Nathalie Holz; Nilakshi Vaidya; Henrik Walter; Robert Whelan; Gunter Schumann; Oliver D. Howes; Mitul A. Mehta; Giulio Pergola
err分享
err收藏
61 Differential Pattern of Disease Recurrence in Resected Renal Cell Carcinoma Patients Treated with Adjuvant Pembrolizumab Versus Observation: A Propensity Score-Weighted Analysis61 接受辅助性帕博利珠单抗治疗与观察治疗的切除性肾细胞癌患者疾病复发的差异模式:一项倾向性评分加权分析
err2026-09-02
err0
errOAAI
errLiliana Ascione; Marco Stellato; Alessio Polymeropoulos; Elena Verzoni; Razane El Hajj Chehade; Gaelle Nafeh; Bohuslav Melichar; Rana R McKay; Francesco Massari; Daniel Y C Heng; Parker Baumgarten; Martin Zarba; Irene Tsung; Wadih Issa; Tian Zhang; Hernan Javier Cutuli; Tom Ferguson; Sebastiano Buti; Maria Baronchelli; Sarah Scagliarini; Toni K Choueiri; Giuseppe Procopio
err分享
err收藏
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations奥拉帕利在全球真实世界中对具有同源重组修复改变的转移性去势抵抗性前列腺癌患者的疗效
err2026-08-31
err0
errOAAI
errLorena Incorvaia; Daniele Santini; Marc R. Matrana; Marco Maruzzo; Ray Manneh Kopp; Lorenzo Antonuzzo; Sergio Bracarda; Deniz Tural; Giuseppe Procopio; Maria T. Bourlon; Orazio Caffo; Martin Ignacio Zapata Laguado; Massimo Di Maio; Brigida Anna Maiorano; Vincenza Conteduca; Sabrina Rossetti; Helga Lipari; Thomas Büttner; Mimma Rizzo; Yüksel Ürün; Carlo Messina; Fernando Sabino Marques Monteiro; Andrey Soares; Mattia Puglisi; Alice Principi; Eleonora Lai; Giulia Mammone; Marco Stellato; Ilaria Depetris; Tancredi Didier Bazan Russo; Isadora Yasbick Spricido; Camila Bobato Lara Gismondi; Francesco Massari; Nicola Pavan; Matteo Santoni; Tarek Taha
err分享
err收藏
Sex-based analysis of first-line immune-based combinations in intermediate/poor-risk papillary, chromophobe, and unclassified renal cell carcinoma: an ARON-1 subanalysis基于性别的中危/高危乳头状、嗜酸性细胞和未分类肾细胞癌一线免疫联合疗法分析:ARON-1研究的亚组分析
err2026-08-30
err0
errOAAI
errPI Paola I. Valdez-Sandoval †; EL Evelyn L. Beas-Lozano †; ZW Zin W. Myint; JK Jakub Kucharz; VM Veronica Mollica; AR Alessandro Rizzo; TT Tarek Taha; JL Johannes Landmesser; EP Esther Pérez Calabuig; JA Jawaher Ansari; CO Cinzia Ortega; RK Ravindran Kanesvaran; DB Dipen Bhuva; AZ Anca Zgura; OF Ondrej Fiala; JM Javier Molina-Cerrillo; SB Sebastiano Buti; FM Francesco Massari; MF Maria Fernanda Esparza-Orozco; MS Matteo Santoni ‡; MT Maria T. Bourlon ‡
err分享
err收藏
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis接受免疫检查点抑制剂治疗的癌症患者中的肌炎:ARON-MOUSEION-017系统评价与荟萃分析
err2026-08-14
err0
PREAI
errElsa Vitale; Gerardo Cazzato; Lorenza Maistrello; Mario Della Mura; Mauro Francesco Pio Maiorano; Francesco Ciccimarra; Oronzo Brunetti; Concetta Calabrò; Brigida Anna Maiorano; Fernando Sabino Marques Monteiro; Enes Erul; Francesco Massari; Alessandro Rizzo; Matteo Santoni
err分享
err收藏
Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study)基线疾病特征和铂类药物敏感性作为顺铂为基础化疗、阿维鲁姆单抗维持治疗和恩沃利单抗维多汀序贯疗法在晚期尿路上皮癌中的预后预测因素(ARON-2EV研究)
err2026-07-29
err0
PREAI
errMimma Rizzo; Sebastiano Buti; Ondřej Fiala; Lorena Incorvaia; Javier Molina-Cerrillo; Maria T. Bourlon; Wataru Fukuokaya; Fumihiko Urabe; Se Hoon Park; Karl Mayrhofer; Renate Pichler; Dora Niedersuess-Beke; Tarek Taha; Thomas Büttner; Aristotelis Bamias; Emmanuel Seront; Daniele Santini; Luciano Stumbo; Alejo Rodriguez-Vida; Francesco Massari; Fernando Sabino Marques Monteiro; Andrey Soares; Enrique Grande; Matteo Santoni
err分享
err收藏
Real-world incidence of G3-G4 adverse events with enfortumab vedotin in patients with advanced urothelial carcinoma (ARON-2EV study)
err2026-07-29
err0
errOAAI
errPatrizia Giannatempo; Shilpa Gupta; Mimma Rizzo; Karl Mayrhofer; Renate Pichler; Dora Niedersuess-Beke; Ondrej Fiala; Javier Molina-Cerrillo; Marc R. Matrana; Randi Kinhel; Luca Galli; Alessia Salfi; Tomas Buchler; Alina Pirshtuk; Jawaher Ansari; Anca Zgura; Ray Manneh Kopp; Giandomenico Roviello; Jindrich Kopecky; Kirstin Binz; Akihiro Yano; Martin Angel; Se Hoon Park; Ravindran Kanesvaran; Zin W. Myint; Yüksel Ürün; Francesco Massari; Fernando Sabino Marques Monteiro; Kannan Sridharan; Matteo Santoni
err分享
err收藏
The impact of relative dose intensity on pathological complete response in neoadjuvant chemotherapy of muscle-invasive urothelial cancer: a multicenter retrospective study相对剂量强度对肌肉浸润性尿路上皮癌新辅助化疗中病理完全缓解的影响:一项多中心回顾性研究
err2026-07-02
err0
errOAAI
errGiuseppe Neola; Fabiano Flauto; Carmine Caso; Giuseppina Montuori; Marco Maruzzo; Eleonora Lai; Giuseppe Luigi Banna; Michele Maffezzoli; Mimma Rizzo; Francesco Massari; Veronica Mollica; Sarah Scagliarini; Vincenza Conteduca; Patrizia Giannatempo; Alessandro Rametta; Brigida Anna Maiorano; Gaetano Facchini; Edoardo Lenci; Rosa Tambaro; Francesco Grillone; Davide Bosso; Felice Crocetto; Ciro Imbimbo; Alberto Servetto; Roberto Bianco; Luigi Formisano; null
err分享
err收藏
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study)HERO评分在恩沃利单抗治疗的转移性尿路上皮癌中的真实世界预后评估(ARON-2EV研究)
err2026-07-01
err0
PREAI
errRoviello, G.; Ciccimarra, F.; Urabe, F.; Melichar, B.; Studentova, H.; Niedersuess-Beke, D.; Mota, A.; Buttner, T.; de Liano, A. Gomez; Yano, A.; Myint, Z. W.; Kopp, R. M.; Zgura, A.; Pinto, A.; Angel, M.; Tural, D.; Kanesvaran, R.; Urun, Y.; Molina-Cerrillo, J.; Monteiro, F. S. Marques; Massari, F.; Fiala, O.; Santoni, M.; Antonuzzo, L.; Rizzo, A.
err分享
err收藏
Microplastics as both a driver of genitourinary cancers and a deliverer of treatments微塑料既是泌尿生殖系统癌症的驱动因素,也是治疗药物的递送载体
err2026-05-27
err0
errOAAI
errKannan Sridharan; Brigida Anna Maiorano; Farah Rehan; Francesca Maradonna; Elisabetta Giorgini; Tarek Taha; Javier Molina-Cerrillo; Sebastiano Buti; Francesco Piva; Francesco Massari; Matteo Santoni
err分享
err收藏
PSMA-PET imaging in prostate cancer patients with high-risk biochemical recurrence: implications from an “EMBARK-Like” cohortPSMA-PET成像在高风险生化复发的 prostate cancer 患者中的应用:来自“EMBARK-Like”队列的启示
err2026-02-25
err0
PREAI
errMatteo Droghetti; Valerio Pirelli; Francesco Ceci; Andrea Farolfi; Matteo Bauckneht; Francesco Lanfranchi; Andrea Di Giorgio; Paolo Castellucci; Caterina Maria Paola Sgro; Carlos Artigas; Jose Leite; Paola Corona; Qaid Ahmed Shagera; Renata Moreira; Christian González; Marcelo Queiroz; Felipe de Galiza Barbosa; Guido Rovera; Desiree Deandreis; Sara Tamburini; Lorenzo Nanni; Federico Bevilacqua; Pietro Piazza; Angelo Mottaran; Veronica Mollica; Francesco Massari; Stefano Fanti; Lorenzo Bianchi; Riccardo Schiavina
err分享
err收藏
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features睾丸绒毛膜癌中Nectin-4表达的新见解及其Enfortumab Vedotin的潜在治疗: 多机构系列分析及其与临床病理特征的关联
err2026-01-21
err0
PREAI
errCostantino Ricci; Luisa Di Sciascio; Francesca Ambrosi; Agnese Orsatti; Alessia Grillini; Eugenia Franchini; Veronica Mollica; Francesco Massari; Federico Mineo Bianchi; Francesco Vasuri; João Lobo; Nuno Tiago Tavares; Fernanda Fernandes-Pontes; Andres Martin Acosta; Michelangelo Fiorentino
err分享
err收藏
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study恩扎卢替尼在转移性激素敏感前列腺癌中的应用:国际、多中心真实世界ARON-3研究的结果
err2026-01-08
err0
errOAAI
errThomas Büttner; Mimma Rizzo; Laura Bernal Vaca; Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Alvaro Juárez; Tomas Buchler; Emmanuel Seront; Jakub Kucharz; María Natalia Gandur Quiroga; Maria T. Bourlon; Martin Bögemann; Jindrich Kopecky; Pasquale Rescigno; Ondrej Fiala; Alejo Rodriguez-Vida; Zin W. Myint; Yüksel Ürün; Sarah Scagliarini; Alexandr Poprach; Diana Matthews; Haoran Li; Alessandro Rizzo; Alessandra Mosca; Edoardo Lenci; Bohuslav Melichar; Mike Wenzel; Philipp Mandell; Francesco Massari; Emmanuel S. Antonarakis; Matteo Santoni
err分享
err收藏
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project接受恩沃利单抗维多汀治疗的局部晚期或转移性尿路上皮癌患者的骨转移:ARON-2EV项目真实世界研究
err2025-12-29
err0
errOAAI
errAlessandro Rizzo; Zin W. Myint; Francesco Ciccimarra; Anca Zgura; Marc R. Matrana; Thomas Büttner; Jindrich Kopecky; Alejo Rodriguez Vida; Mimma Rizzo; Kazutoshi Fujita; Oronzo Brunetti; Daniele Santini; Se Hoon Park; Luigi Formisano; Alexandr Poprach; Jakub Kucharz; Maria Colomba Comes; Samantha Bove; Annarita Fanizzi; Raffaella Massafra; Gerardo Cazzato; Fernando Sabino Marques Monteiro; Veronica Mollica; Francesco Massari; Javier Molina Cerrillo; Matteo Santoni
err分享
err收藏
Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-Analysis免疫检查点抑制剂治疗癌症患者中的输注相关反应:ARON-MOUSEION-013系统评价与荟萃分析
err2025-12-13
err0
errOAAI
errElsa Vitale; Alessandro Rizzo; Lorenza Maistrello; Omar Cauli; Oronzo Brunetti; Fernando Sabino Marques Monteiro; Andrey Soares; Matteo Santoni; Veronica Mollica; Francesco Massari
err分享
err收藏
Reply to: Comments on Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)
err2025-12-01
err0
PREAI
errMolina-Cerrillo, Javier; Roviello, Giandomenico; Fiala, Ondrej; Taha, Tarek; Buti, Sebastiano; Rizzo, Mimma; Massari, Francesco; Monteiro, Fernando Sabino Marques; Santoni, Matteo
err分享
err收藏
Advancements of investigational agents for renal cell carcinoma: what clinical progress have we seen in the last 5 years?
err2025-12-01
err0
PREAI
errDanielli, Linda; Rosellini, Matteo; Tassinari, Elisa; Marchetti, Andrea; Mollica, Veronica; Santoni, Matteo; Massari, Francesco
err分享
err收藏
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study转移时间作为转移性尿路上皮癌的预后因素:ARON-2研究的结果
err2025-11-21
err0
PREAI
errRenate Pichler; Gerald Klinglmair; Kirstin Binz; Enrique Grande; Alina Pirshtuk; Hideki Takeshita; Yüksel Ürün; Javier Molina-Cerrillo; Zin W. Myint; Alfonso Gómez de Liaño; Augusto Mota; Alessia Salfi; Wataru Fukuokaya; Enrico Sammarco; Martin Angel; Jakub Kucharz; Deniz Tural; Ondřej Fiala; Alejo Rodriguez-Vida; Franco Morelli; Alexandr Poprach; Mobin Safi; Alvaro Pinto; Francesco Massari; Sebastiano Buti; Shilpa Gupta; Fernando Sabino Marques Monteiro; Andrey Soares; Nicola Battelli; Ravindran Kanesvaran; Matteo Santoni
err分享
err收藏